Milestone Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
Milestone Pharmaceuticals Inc.‘s stocks are currently a part of 23 hedge funds’ portfolios, which represents 27.52% of the total amount of its stocks outstanding. This makes up a total of 11.35M shares of Milestone Pharmaceuticals Inc.. Compared to the previous quarter, the number fell by -52.87% or -12.73M shares fewer. As for the holding position changes, 39.13% (9) of current hedge fund investors increased the number of shares held, 26.09% (6) of current holders sold a part of the shares held, and 21.74% (5) closed the holdings completely. 4 hedge funds are new holders of Milestone Pharmaceuticals Inc. stock in Q1 2023, it is 17.39% of total holders.
Hedge funds holding Milestone Pharmaceuticals (Q2 2016 – Q1 2023)
| Q2 2016 | 1 |
|---|---|
| Q3 2016 | 1 |
| Q4 2016 | 1 |
| Q1 2017 | 0 |
| Q2 2019 | 24 |
| Q3 2019 | 22 |
| Q4 2019 | 24 |
| Q1 2020 | 15 |
| Q2 2020 | 22 |
| Q3 2020 | 28 |
| Q4 2020 | 32 |
| Q1 2021 | 31 |
| Q2 2021 | 26 |
| Q3 2021 | 25 |
| Q4 2021 | 26 |
| Q1 2022 | 26 |
| Q2 2022 | 28 |
| Q3 2022 | 45 |
| Q4 2022 | 54 |
| Q1 2023 | 23 |
Hedge funds changes in Milestone Pharmaceuticals positions (Q2 2016 – Q1 2023)
| Q2 2016 | 0 | 0 | 0 | 0 | 1 |
|---|---|---|---|---|---|
| Q3 2016 | 0 | 0 | 0 | 0 | 1 |
| Q4 2016 | 0 | 0 | 0 | 0 | 1 |
| Q1 2017 | 0 | 0 | 0 | 1 | -1 |
| Q2 2019 | 24 | 0 | 0 | 0 | 0 |
| Q3 2019 | 1 | 3 | 5 | 3 | 10 |
| Q4 2019 | 4 | 7 | 5 | 2 | 6 |
| Q1 2020 | 4 | 3 | 7 | 11 | -10 |
| Q2 2020 | 12 | 2 | 1 | 5 | 2 |
| Q3 2020 | 12 | 6 | 3 | 6 | 1 |
| Q4 2020 | 8 | 14 | 6 | 4 | 0 |
| Q1 2021 | 4 | 10 | 9 | 5 | 3 |
| Q2 2021 | 2 | 8 | 7 | 7 | 2 |
| Q3 2021 | 2 | 4 | 11 | 3 | 5 |
| Q4 2021 | 4 | 9 | 4 | 3 | 6 |
| Q1 2022 | 3 | 12 | 3 | 3 | 5 |
| Q2 2022 | 4 | 6 | 8 | 1 | 9 |
| Q3 2022 | 19 | 10 | 12 | 2 | 2 |
| Q4 2022 | 24 | 17 | 7 | 15 | -9 |
| Q1 2023 | 4 | 9 | 6 | 5 | -1 |
Hedge funds changes in Milestone Pharmaceuticals stock options (Q2 2016 – Q1 2023)
| Q2 2016 | 0 | 0 |
|---|---|---|
| Q3 2016 | 0 | 0 |
| Q4 2016 | 0 | 0 |
| Q1 2017 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 523,000 |
| Q4 2020 | 251,000 | 0 |
| Q1 2021 | 2,682,000 | 339,000 |
| Q2 2021 | 2,185,000 | 416,000 |
| Q3 2021 | 2,741,000 | 174,000 |
| Q4 2021 | 6,000 | 0 |
| Q1 2022 | 1,168,000 | 0 |
| Q2 2022 | 1,766,000 | 273,000 |
| Q3 2022 | 11,571,000 | 9,090,000 |
| Q4 2022 | 1,947,484 | 468,468 |
| Q1 2023 | 762,000,000 | 168,632,000 |